CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway-Reference-Cited by-同舟云学术

CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway

Published:2017-11-27 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Xu Chunlan,Ghali Sally,Wang Jiani,Shih David Q.,Ortiz Christina,Mussatto Caroline C.,Lee Elaine C.,Tran Diana H.,Jacobs Jonathan P.,Lagishetty Venu^ORCID,Fleshner Phillip,Robbins Lori,Vu Michelle,Hing Tressia C.,McGovern Dermot P. B,Koon Hon Wai

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-16753-z.pdf

Reference34 articles.

1. Hirata, Y., Ihara, S. & Koike, K. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease. Pharmacol Res 113, 574–584, https://doi.org/10.1016/j.phrs.2016.09.044 (2016).

2. Katsanos, K. H. et al. Fast-track drug approval in inflammatory bowel diseases. Ann Gastroenterol 29, 439–444 (2016).

3. Bucki, R. et al. Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection. Antimicrob Agents Chemother 59, 6274–6282, https://doi.org/10.1128/AAC.00653-15 (2015).

4. De, Y. et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192, 1069–1074 (2000).

5. Lai, X. Z. et al. Ceragenins: cholic acid-based mimics of antimicrobial peptides. Acc Chem Res 41, 1233–1240, https://doi.org/10.1021/ar700270t (2008).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein profiles in the transfected oviductal secreting cells of laying hen (Gallus gallus domesticus);Poultry Science;2024-03

2. Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease;Acta Pharmacologica Sinica;2022-07-15

3. Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2;Cellular and Molecular Gastroenterology and Hepatology;2022

4. Elafin inhibits obesity, hyperglycemia, and liver steatosis in high-fat diet-treated male mice;Scientific Reports;2020-07-30

5. TMT-labelled quantitative proteomic analysis to identify the proteins underlying radiation-induced colorectal fibrosis in rats;Journal of Proteomics;2020-07